ADVANCES IN PSORIASIS TREATMENT: COMBINING SECUKINUMAB WITH PHOTOTHERAPY

This article explores the benefits of combining secukinumab, a biologic IL-17 inhibitor, with narrowband UVB phototherapy in treating moderate to severe psoriasis. It presents findings from five patients who demonstrated significant skin clearance and improved quality of life through this combination approach, suggesting that it can be an effective treatment for resistant forms of the disease